September 10, 2019 – Gene William’s Presentation at the HC Wainwright Investor Conference.
Link to presentation http://wsw.com/webcast/hcw5/arfxf/
View/Download PDF of the presentation slides: Click here to access.
Executive Chairman Gene William’s Presentation at the HC Wainwright Investor Conference
No Comments
Company News
- ProMIS Neurosciences Appoints Dr. José Luis Molinuevo to its Scientific Advisory Board January 15, 2020
- ProMIS Neurosciences to present at Sachs 3rd Annual Neuroscience Innovation Forum January 9, 2020
- ProMIS Neurosciences issues Chairman’s Update detailing positive outlook for Alzheimer’s disease therapy, pipeline in 2020 January 8, 2020
Scientific Presentations
- ProMIS Neurosciences: “Best in Class” therapy for misfolded protein diseases, based on a proprietary discovery platform November 6, 2019
- Executive Chairman Gene William’s Presentation at the HC Wainwright Investor Conference September 10, 2019
- CSO Neil Cashman’s overview of ProMIS’ unique capability to selectively target toxic, misfolded proteins that are root causes of neurodegenerative diseases August 12, 2019